Related Experiment Video
Updated: Aug 11, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
Intermethod variability of sodium and potassium results: patients' sera and commercially available control sera
G Cattozzo1, A Fabi, C Franzini
1Laboratorio di Analisi, Ospedale C. Ondoli, Angera (Varese), Italy.
Abstract:
Sodium and potassium were measured in sets of 102 to 107 patients sera, and in 31 commercially available control sera. The results from four routine analytical methods/systems (indirect potentiometry: two; direct potentiometry and enzymatic assay: one each) were compared with those from a flame photometry-based reference method. In the assay of patient sera, substantial agreement was observed in some comparisons, clinically relevant bias in others. The inter-assay changes observed for the control sera differed significantly from those shown by the patients sera (i.e. commercial control sera were non-commutable) in about 12% of the comparisons, as a whole. Recalculation of serum sample results with a single control serum as calibrator lowered or increased the bias originally present according to whether the serum itself was commutable or not. Moreover, the inter-method variability in the assay of commercial control sera was lower with commutable sera, higher with non-commutable sera. With the exception of liquid sera stabilized with ethylene glycol, there was no evident link between any specific characteristic of the commercial control sera (matrix and physical state) and their degree of commutability.

